The cervical cancer diagnostic testing market is projected to reach US$ 7,165.92 million by 2028


Vaibhav20

Uploaded on Jan 18, 2022

Cervical cancer has a significant mortality rate (almost 50%), which can be lowered with early detection and prevention. Precancerous alterations offer opportunities for prevention and treatment because disease progression is often delayed.

Comments